Search

Your search keyword '"Kohner, E. M."' showing total 576 results
Start Over Author "Kohner, E. M."
576 results on '"Kohner, E. M."'

22. Detecting Diabetic Retinopathy [with Reply]

Author

Higgs, E. R., Harney, B. A., Hughes, D. S., Holden, R., Morgan, S. J., Newsom, Richard, Wareham, Nicholas J., Taylor, Roy, Kohner, E. M., Dean-Hart, J. C., and Burns-Cox, C. J.

Published
1991

36. Fourth Annual Meeting of the European Association for the study of diabetes: Louvain, Belgium, July 22–24, 1968

Author

Abrams, M. E., Boyns, D. R., Crossley, J. R., Jarrett, R. J., Keen, H., Andreani, D., Menzinger, G., Fallucca, F., Alibebti, A., Tamburrane, G., Andreev, D., Ditzov, S., Dashev, G., Strashimirov, D., Appels, A., Willms, B., Söling, H. D., Asfeldt, V. H., Bacanu, Gh., Bakker, B., Roerdink, F. H., Bouman, P. R., Coert, A., Jaspers, N. M. V., Barta, L., Beckmann, R., Berger, W., Beringer, A., Geyer, G., Mösslacher, H., Tragl, K. H., Waldhäusl, W., Beyer, J., Schöffling, K., Ditschuneit, H., Raptis, S., Wolf, E., Güntert, E., Pfeiffer, E. F., Bilic, N., Felber, J. P., Bojanowicz, K., Zubowski, A., Rybarczyk, Z., Bonessa, C., Cremonini, L., Borrebaek, B., Spydevold, Ø., Botterman, P., Dieterle, P., Scriba, P. C., Schwarz, K., Boucher, B. J., Mashiter, K., Stimmler, L., Vince, F., Walters, P., Csorba, T. R., Butterfield, W. J. H., Whichelow, M. J., Boyns, A. R., Mahler, R., Pearce, N., Bruni, B., Büber, V., Felber, J. -P., Vannotti, A., Buchanan, K. D., Vance, J. E., Dinstl, K., Williams, R. H., Cox, B. D., Cohen, N. M., Alexander, D. P., Britton, H. G., Nixon, D. A., Parker, R. A., Cegrell, L., Chance, G. W., Albutt, E. C., Chlouverakis, C., White, P., Christensen, N. Juel, Contesse, G., Pathé, G., Crabbé, J., Scarlata, J., Crepaldi, G., Muggeo, M., Tiengo, A., Enzi, G., Federspil, G., Trisotto, A., Czyżyk, A., Gregor, A., Dawidowicz, A., de Gasparo, M., Malherbe, Che., Thomas, K., Hoet, J. J., De Leeuw, I., Dérot, M., Rathery, M., Rosselin, G., Devlin, James G., Duggan, Marion, Dubach, U. C., Forgò, I., Fellin, R., Muggeo, H., Fagerberg, S. B., Axelsson, A., Fankhauser, S., Morell, B., Federlin, K., Flad, H. -D., Kriegbaum, D., Rivier, D. A., Fellmann, E., Glaubitt, D., Hönlinger, U., Ulrich, I., Wulff, K., Förster, H., Brauch, K., Mehnert, H., Dittmar, F., Frerichs, H., Creutzfeldt, W., Fbeytag, G., Schabschmidt, W., Klöppel, G., Friedler, Denise, Benhamou, J. P., Lubetzki, J., Azerad, E., Gnudi, A., Coscelli, C., Palmari, V., Valenti, G., Btttturini, U., Gomez, F., Guidoux-Grassi, L., Maerki, J., Guidoux, R., Groen, J. J., Grüneklee, D., Liebermeister, H., Schilling, W. H., Solbach, H. G., Herberg, L., Daweke, H., Guy-Grand, B., Tutin, M., Bour, H., Hadden, D. R., Harley, J. M. G., Montgomery, D. A. D., Mackay, J. S., Heding, Lise G., Hellerström, C., Stork, H., Westman, S., Schmidt, F. H., Boehringer, C. F., GmbH, Söhne, Hepp, Dieter, Challoner, David R., Williams, Robert H., Berger, M., Gries, F. A., Preiss, H., Jahnke, K., Herman, J. B., Keynam, A., Hill, D. M., Munro-Faure, A. D., Anderson, J., Horn, Z., Jakob, A., Humbel, R. E., Buxtorf, U., Froesch, E. R., Track, N. S., Kaeding, A., Karmann, H., Mialhe, P., Kasemir, H., Paulus, U., Steinhilber, S., Kerp, L., Kohner, E. M., Oakley, N. W., Fraser, T. Russell, and Kühnau, Jr., J.

Published
1968
Full Text
View/download PDF

37. British Diabetic Association Abstracts Medical and Scientific Section, Spring Meeting: Oxford, 5th and 6th April 1968

Author

Garratt, C. J., Jones, A. H., Miles, L. E. M., Hales, C. N., Manchester, K. L., Buchanan, K. D., Vance, J. E., Morgan, A., Williams, R. H., Track, Norman S., Caird, F. I., Kohner, E. M., Roth, J., Bulpitt, C. J., Dollery, C. T., Fraser, T. Russell, Weight, A. D., Oakley, N. W., Hartog, M., Joplin, G. F., Mayne, B. E., Weaver, J. A., Bridges, J. M., Butterfield, W. J. H., Keates, J. S., Devlin, James G., Stephenson, Nuala, Malherbe, C., Heller, F., de Gasparo, M., Hoet, J. J., Robertson, W. B., Robinson, D. S., Kingsbury, K. J., O'Sullivan, John B., Keen, H., Jarrett, R. J., Chlouverakis, C., Boyns, D. A., Pyke, D. A., Hardwick, G., Catterall, R. C. F., Kemball, Margaret, Nourse, Christopher, Sohiff, David, Tiernan, Ray, Bevan, A. T., Hockaday, T. D. R., Jelfs, R., Bewsher, P. D., Scott, R. D. M., Stowers, J. M., Adnitt, P. I., Oleesky, S., Schnieden, H., Rigas, A. N., Bittles, A., Hadden, D. R., Montgomery, D. A. D., Bingle, J. P., McKiddie, M. T., Albutt, E. C., Chance, G. W., Hirsch J., Farquhar, J. W., Ahrens, E. H., Peterson, M. L., Stoffel, W., Dayton S., Hashimoto, S., Pearce, M. L., Cohen, N. M., Alexander, D. Pauline, Britton, H. G., Nixon, D. A., Parker, R. A., Campbell, N., Oakley, W. G., Peel, J., Taylor, K. W., Boyns, A. R., Mahler, R., Pearce, N., Kaden, M., Field, J. B., Matty, A. J., and Qureshi, M. A.

Published
1968
Full Text
View/download PDF

41. Book reviews

Author

Teuscher, A., Cohen R. D., Alberti, K. G. M. M., Nattrass, M., Pfeiffer, E. F., and Kohner, E. M.

Published
1980
Full Text
View/download PDF

46. Growth of bovine retinal pericytes and endothelial cells in high hexose concentrations

Author

Porta, M., Molinatti, P. A., Dosso, A. A., Frances Williams, Brooks, R. A., and Kohner, E. M.

Subjects
Glucose, Cell Death, Animals, Galactose, Retinal Vessels, Cattle, Mannitol, DNA, Endothelium, Vascular, Cell Division, Cells, Cultured, Hexoses, Thymidine
Abstract

Selective loss of capillary pericytes occurs early in diabetic and galactosemic retinopathies, at a stage when endothelial cells are still spared. To ascertain whether such loss is directly related to high hexose concentrations, the replication of bovine retinal pericytes and endothelial cells was studied by culturing them in media containing 5.6 mmol/l glucose alone and enriched with extra glucose, mannitol or galactose to achieve final concentrations of 16.7, 27.8 and 50.0 mmol/l. At the end of the incubation there were significantly less pericytes/culture cell in 16.7 mmol/l glucose (341 +/- 78 x 10(3), mean +/- SEM, p = 0.027) and galactose (304 +/- 55 x 10(3), p = 0.046) than in 5.6 mmol/l glucose (417 +/- 98 and 355 +/- 75 x 10(3) for separate experiments, respectively). Mannitol had no such effect (343 +/- 52 vs. 337 +/- 52 x 10(3). Endothelial cells did not change in number, except in 50.0 mmol/l glucose (533 +/- 66 vs. 629 +/- 67 x 10(3) at 5.6 mmol/l; p = 0.026) and 50.0 mmol/l galactose (440 +/- 48 vs. 592 +/- 51 x 10(3); p = 0.013). To verify if these effects are due to decreased replication, the uptake of 3H-thymidine was measured in pericytes and endothelial cells subjected to the same concentrations of glucose, mannitol and galactose. In pericytes, thymidine uptake was reduced in the presence of 16.7 mmol/l glucose (p = 0.003, compared to 5.6 mmol/l) and galactose (p = 0.027) but not mannitol. Pericyte counts and thymidine uptake was reduced for concentrations of glucose, galactose and mannitol higher than 16.7 mmol/l.(ABSTRACT TRUNCATED AT 250 WORDS)

Published
1994

48. Protocols for screening and treatment of diabetic retinopathy in Europe

Author

Kohner, E. M. and Massimo Porta

Subjects
Europe, Diabetic Retinopathy, Vision Screening, Fundus Oculi, Data Collection, Humans, Macula Lutea, Cataract Extraction, Light Coagulation, Retinal Neovascularization
Abstract

Diabetes eye complications, and particularly diabetic retinopathy, are the major cause of blindness in the working age groups of industrialised countries. Laser photocoagulation has been proven to reduce blindness due to retinopathy by at least 60% but even more patients would benefit if treatment were delivered at an early enough stage. High risk retinopathy, though, does not cause visual symptoms and when the latter occur it is often too late to reverse them. Hence, a screening programme for diabetic retinopathy should aim at detecting patients at risk when they can still be effectively treated. This can be obtained by regularly checking the patients' eyes. Its target, as defined by the joint World Health Organisation/International Diabetes Federation Saint Vincent Declaration Working Group, is to reduce diabetes-related blindness by one third or more in the next 5 years. The number of persons to be screened is high, 30,000/million total population/year, but available data indicate that this is feasible and that the initial investments in professional and material resources are more than justified by the reduction of preventable blindness and of the financial burdens that go with it. Indeed, prevention of the major cause of blindness in the working age should rate the same priority as other widely deployed programmes, such as those to screen for cancer, neonatal hypothyroidism and phenylketonuria. The concerted action of government health departments, patients' and professional associations will be vital for the successful implementation of this programme. The texts of this document (a protocol for the screening of diabetic retinopathy and cataract), Appendix 1 (data collection card) and Appendix 2 (informative leaflet for the patients) were approved by 57 specialists, representing 30 diabetic and ophthalmic societies from 21 European countries, and endorsed for translation into all European languages and distribution at the appropriate levels.

Published
1991

Catalog

Books, media, physical & digital resources
See catalog results